Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Bispecific antibodies targeting BCMA or GPRC5D are highly... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
0
Authors
Maximilian Merz
37 more
Maximilian Merz
•
Danai Dima
35 more
•
Nico Gagelmann
Published
December 5, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Blood Cancer Journal
Topics
Biology
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1038/s41408-024-01197-2
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Blood Cancer Journal
Topics
Biology
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1038/s41408-024-01197-2
License
CC-BY
